Clean Yield Group lowered its stake in shares of Colgate-Palmolive (NYSE:CL) by 0.9% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 61,088 shares of the company’s stock after selling 530 shares during the quarter. Colgate-Palmolive accounts for 1.9% of Clean Yield Group’s holdings, making the stock its 9th biggest holding. Clean Yield Group’s holdings in Colgate-Palmolive were worth $4,713,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in CL. Capital World Investors purchased a new position in Colgate-Palmolive during the 1st quarter valued at $829,740,000. California Public Employees Retirement System boosted its holdings in Colgate-Palmolive by 4.4% during the 2nd quarter. California Public Employees Retirement System now owns 4,842,429 shares of the company’s stock valued at $354,756,000 after acquiring an additional 202,550 shares during the period. Swiss National Bank boosted its holdings in Colgate-Palmolive by 0.7% during the 2nd quarter. Swiss National Bank now owns 3,702,573 shares of the company’s stock valued at $271,250,000 after acquiring an additional 25,600 shares during the period. Sarasin & Partners LLP boosted its holdings in Colgate-Palmolive by 15.2% during the 2nd quarter. Sarasin & Partners LLP now owns 3,305,185 shares of the company’s stock valued at $242,138,000 after acquiring an additional 436,889 shares during the period. Finally, GUARDCAP ASSET MANAGEMENT Ltd boosted its holdings in Colgate-Palmolive by 29.3% during the 2nd quarter. GUARDCAP ASSET MANAGEMENT Ltd now owns 2,820,132 shares of the company’s stock valued at $206,603,000 after acquiring an additional 639,353 shares during the period. 76.74% of the stock is currently owned by hedge funds and other institutional investors.

In related news, CEO Noel R. Wallace sold 85,929 shares of the company’s stock in a transaction dated Wednesday, August 5th. The stock was sold at an average price of $76.37, for a total transaction of $6,562,397.73. Following the transaction, the chief executive officer now directly owns 282,097 shares of the company’s stock, valued at approximately $21,543,747.89. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, VP Philip G. Shotts sold 401 shares of the company’s stock in a transaction dated Monday, September 28th. The shares were sold at an average price of $77.29, for a total value of $30,993.29. Following the transaction, the vice president now directly owns 41,263 shares in the company, valued at $3,189,217.27. The disclosure for this sale can be found here. Over the last three months, insiders sold 256,994 shares of company stock valued at $19,678,851. Corporate insiders own 0.78% of the company’s stock.

A number of research firms recently issued reports on CL. Morgan Stanley boosted their price objective on Colgate-Palmolive from $78.00 to $80.00 and gave the company an “equal weight” rating in a report on Monday, August 3rd. Royal Bank of Canada reiterated a “buy” rating and issued a $88.00 target price on shares of Colgate-Palmolive in a report on Thursday, July 30th. TheStreet upgraded Colgate-Palmolive from a “c+” rating to a “b+” rating in a report on Friday, July 31st. Finally, Deutsche Bank Aktiengesellschaft upped their target price on Colgate-Palmolive from $75.00 to $78.00 and gave the stock a “hold” rating in a report on Monday, August 3rd. Three equities research analysts have rated the stock with a sell rating, four have given a hold rating and six have issued a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus price target of $75.27.

Shares of CL traded up $0.60 during trading hours on Friday, hitting $80.31. The company had a trading volume of 2,963,577 shares, compared to its average volume of 4,302,619. The company has a market capitalization of $68.86 billion, a PE ratio of 26.86, a price-to-earnings-growth ratio of 4.63 and a beta of 0.59. The company has a current ratio of 0.92, a quick ratio of 0.59 and a debt-to-equity ratio of 9.40. Colgate-Palmolive has a one year low of $58.49 and a one year high of $80.99. The company’s fifty day moving average price is $77.55 and its two-hundred day moving average price is $73.84.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, July 31st. The company reported $0.74 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.69 by $0.05. The firm had revenue of $3.90 billion during the quarter, compared to analyst estimates of $3.78 billion. Colgate-Palmolive had a return on equity of 559.34% and a net margin of 16.13%. The business’s revenue for the quarter was up .8% compared to the same quarter last year. During the same period in the previous year, the company posted $0.72 EPS. Analysts forecast that Colgate-Palmolive will post 2.96 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Monday, November 16th. Stockholders of record on Friday, October 23rd will be given a $0.44 dividend. This represents a $1.76 annualized dividend and a dividend yield of 2.19%. The ex-dividend date is Thursday, October 22nd. Colgate-Palmolive’s payout ratio is 62.19%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.

Read More: Forex

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.